12 December 2019 – HOCHDORF (SWX: HOCN) has sold its 51% majority stake in companies of the Pharmalys Group acquired at the end of 2016 to Pharmalys Invest Holding, controlled by Amir Mechria. The selling price is around CHF 100 million.

Walder Wyss AG acted as counsel to HOCHDORF in this transaction. The team was led by Urs Schenker (Counsel, Corporate/M&A) and Thiemo Sturny (Partner, Corporate/M&A) and further included Christoph Zaugg (Associate, Corporate/M&A) as well as Manuel Bigler (Associate, IP).